Trademark: 97325024
Status Date
Friday, March 8, 2024
Filing Date
Tuesday, March 22, 2022
Published for Opposition
Tuesday, February 28, 2023
5 Pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression
Mar 9, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 8, 2024
Allowed Principal Register - Sou Accepted
Mar 1, 2024
Statement Of Use Processing Complete
Feb 6, 2024
Use Amendment Filed
Feb 29, 2024
Case Assigned To Intent To Use Paralegal
Feb 6, 2024
Teas Statement Of Use Received
Oct 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 24, 2023
Sou Extension 1 Granted
Oct 24, 2023
Sou Extension 1 Filed
Oct 24, 2023
Sou Teas Extension Received
Apr 25, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2023
Published For Opposition
Feb 8, 2023
Notification Of Notice Of Publication E-Mailed
Jan 26, 2023
Approved For Pub - Principal Register
Jan 25, 2023
Teas/Email Correspondence Entered
Jan 25, 2023
Correspondence Received In Law Office
Jan 25, 2023
Teas Response To Office Action Received
Jan 10, 2023
Notification Of Non-Final Action E-Mailed
Jan 10, 2023
Non-Final Action E-Mailed
Jan 10, 2023
Non-Final Action Written
Jan 3, 2023
Assigned To Examiner
Mar 28, 2022
New Application Office Supplied Data Entered
Mar 25, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
